Tivity Health (TVTY) Given Overweight Rating at Cantor Fitzgerald

Share on StockTwits

Tivity Health (NASDAQ:TVTY)‘s stock had its “overweight” rating reissued by equities researchers at Cantor Fitzgerald in a report issued on Wednesday, The Fly reports. They presently have a $40.00 price objective on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 78.02% from the stock’s previous close.

TVTY has been the subject of a number of other research reports. Zacks Investment Research lowered shares of Tivity Health from a “buy” rating to a “hold” rating in a research report on Tuesday, December 18th. BidaskClub lowered shares of Tivity Health from a “hold” rating to a “sell” rating in a research report on Thursday, February 7th. Chardan Capital reiterated a “buy” rating and issued a $31.00 target price (down previously from $41.00) on shares of Tivity Health in a research report on Friday, February 1st. ValuEngine lowered shares of Tivity Health from a “hold” rating to a “sell” rating in a research report on Tuesday, December 11th. Finally, Barrington Research reiterated a “buy” rating and issued a $50.00 target price on shares of Tivity Health in a research report on Tuesday, November 6th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and seven have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $32.25.

Tivity Health stock opened at $22.47 on Wednesday. The stock has a market cap of $871.41 million, a PE ratio of 9.60, a PEG ratio of 0.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.98 and a quick ratio of 0.98. Tivity Health has a one year low of $20.41 and a one year high of $44.35.

Tivity Health (NASDAQ:TVTY) last released its quarterly earnings results on Tuesday, February 19th. The company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.57 by $0.16. The business had revenue of $153.04 million during the quarter, compared to analyst estimates of $153.66 million. Tivity Health had a net margin of 16.30% and a return on equity of 31.34%. Equities research analysts predict that Tivity Health will post 2.36 EPS for the current year.

Several large investors have recently bought and sold shares of the company. Piedmont Investment Advisors Inc. boosted its position in shares of Tivity Health by 5.5% during the 4th quarter. Piedmont Investment Advisors Inc. now owns 9,729 shares of the company’s stock valued at $241,000 after purchasing an additional 511 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of Tivity Health by 4.1% during the 4th quarter. Victory Capital Management Inc. now owns 17,112 shares of the company’s stock valued at $425,000 after purchasing an additional 667 shares in the last quarter. State of Alaska Department of Revenue boosted its position in shares of Tivity Health by 5.7% during the 4th quarter. State of Alaska Department of Revenue now owns 13,691 shares of the company’s stock valued at $339,000 after purchasing an additional 737 shares in the last quarter. Advisor Group Inc. boosted its position in shares of Tivity Health by 364.2% during the 4th quarter. Advisor Group Inc. now owns 1,142 shares of the company’s stock valued at $29,000 after purchasing an additional 896 shares in the last quarter. Finally, Enlightenment Research LLC bought a new position in shares of Tivity Health during the 4th quarter valued at about $37,000.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Featured Story: Relative Strength Index

The Fly

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply